Cara Therapeutics | CARA - PE Price to Earnings

Stock Price
3.92
Daily Change
0.25 6.67%
Monthly
7.40%
Yearly
-74.53%
Q1 Forecast
3.80

Cara Therapeutics reported 27.77 in PE Price to Earnings for its fiscal quarter ending in September of 2021.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Chugai Pharma 31.26 5.24 Dec/2025
Cipla 27.74 3.55 Dec/2025
Clal Biotechnology 11.67 2.62 Dec/2022
CSL 16.16 9.59 Dec/2025
Grifols 12.27 4.84 Sep/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025
J&J 23.62 0.86 Dec/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Pacira 52.68 23.44 Dec/2025
Pfizer 14.48 5.18 Dec/2025
RedHill Biopharma 0.04 0.03 Jun/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023